<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font19">and </span>
   <span class="font15">for </span>
   <span class="font15">with </span>
   <span class="font14">patients </span>
   <span class="font14">that </span>
   <span class="font13">was </span>
   <span class="font13">clinical </span>
   <span class="font13">COVID- </span>
   <span class="font13">{background </span>
   <span class="font13">antiviral </span>
   <span class="font12">treatment </span>
   <span class="font12">coronavirus </span>
   <span class="font12">are </span>
   <span class="font12">viral </span>
   <span class="font12">â€". </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">this </span>
   <span class="font12">been </span>
   <span class="font12">drugs </span>
   <span class="font12">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">chloroquine </span>
   <span class="font11">against </span>
   <span class="font11">not </span>
   <span class="font11">respiratory </span>
   <span class="font11">will </span>
   <span class="font11">RNA </span>
   <span class="font11">The </span>
   <span class="font11">have </span>
   <span class="font11">severe </span>
   <span class="font11">trials </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">has </span>
   <span class="font11">LPV/r </span>
   <span class="font11">these </span>
   <span class="font11">were </span>
   <span class="font11">activity </span>
   <span class="font11">drug </span>
   <span class="font11">virus </span>
   <span class="font11">disease </span>
   <span class="font11">efficacy </span>
   <span class="font11">from </span>
   <span class="font11">patients. </span>
   <span class="font11">remdesivir </span>
   <span class="font11">syndrome </span>
   <span class="font11">day </span>
   <span class="font11">favipiravir </span>
   <span class="font11">patient </span>
   <span class="font11">use </span>
   <span class="font11">which </span>
   <span class="font11">However, </span>
   <span class="font11">acute </span>
   <span class="font11">also </span>
   <span class="font11">approved </span>
   <span class="font11">treat </span>
   <span class="font11">treated </span>
   <span class="font10">cell </span>
   <span class="font10">combination </span>
   <span class="font10">could </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">other </span>
   <span class="font10">protease </span>
   <span class="font10">px; </span>
   <span class="font10">results </span>
   <span class="font10">study </span>
   <span class="font10">thus </span>
   <span class="font10">{font-family </span>
   <span class="font10">COVID-. </span>
   <span class="font10">but </span>
   <span class="font10">currently </span>
   <span class="font10">evaluated </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">lung </span>
   <span class="font10">might </span>
   <span class="font10">observed </span>
   <span class="font10">therapies </span>
   <span class="font10">trial </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">HIV </span>
   <span class="font10">addition, </span>
   <span class="font10">al. </span>
   <span class="font10">animal </span>
   <span class="font10">because </span>
   <span class="font10">control </span>
   <span class="font10">double; </span>
   <span class="font10">human </span>
   <span class="font10">infection </span>
   <span class="font10">inhibitors </span>
   <span class="font10">mild </span>
   <span class="font10">one </span>
   <span class="font10">received </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Both </span>
   <span class="font10">China </span>
   <span class="font10">East </span>
   <span class="font10">Middle </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Res; </span>
   <span class="font10">This </span>
   <span class="font10">after </span>
   <span class="font10">and/or </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">case </span>
   <span class="font10">clearance </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">coronaviruses. </span>
   <span class="font10">data </span>
   <span class="font10">evaluate </span>
   <span class="font10">including </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">novel </span>
   <span class="font10">replication </span>
   <span class="font10">report </span>
   <span class="font10">reported </span>
   <span class="font10">solid; </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">symptoms </span>
   <span class="font10">time </span>
   <span class="font10">vitro </span>
   <span class="font10">yet </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(nâ€‰=â€‰), </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">China. </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">IL- </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Med; </span>
   <span class="font10">able </span>
   <span class="font10">already </span>
   <span class="font10">associated </span>
   <span class="font10">being </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">care </span>
   <span class="font10">courier; </span>
   <span class="font10">culture, </span>
   <span class="font10">develop </span>
   <span class="font10">different </span>
   <span class="font10">due </span>
   <span class="font10">during </span>
   <span class="font10">em; </span>
   <span class="font10">hospital </span>
   <span class="font10">ill </span>
   <span class="font10">its </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">mouse </span>
   <span class="font10">ongoing </span>
   <span class="font10">options </span>
   <span class="font10">outcome </span>
   <span class="font10">oxygen </span>
   <span class="font10">patients, </span>
   <span class="font10">pneumonia </span>
   <span class="font10">potential </span>
   <span class="font10">profile </span>
   <span class="font10">pt;} </span>
   <span class="font10">recovery </span>
   <span class="font10">reduce </span>
   <span class="font10">safety </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">therefore </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">treatment. </span>
   <span class="font10">twice </span>
   <span class="font10">two </span>
   <span class="font10">vs. </span>
   <span class="font10">well </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
